ROA new study published in the journal Clinical Gastroenterology and Hepatology suggests that coffee consumption—both caffeinated and decaffeinated—is associated with a reduced risk of liver cirrhosis, liver cancer, and death caused by liver disease. The research analyzed data from over 350,000 participants in the UK Biobank who did not initially have liver cirrhosis or liver cancer. Over 13 years, those drinking five or more cups of coffee daily showed a 32% lower risk of cirrhosis, a 47% lower risk of liver cancer, and a 42% lower risk of dying from liver-related diseases compared to those consuming less coffee. Researchers noted that while these findings highlight potential benefits, they do not establish causation and caution against starting coffee consumption solely for health reasons. The study also found that higher coffee intake was linked to lower levels of fat and iron in the liver, reduced fibrosis and inflammation, and improved markers of liver function.
Lecture du biais (Centre): The article presents scientific findings without overt ideological framing. It reports on medical research, highlights both positive outcomes and limitations, and includes balanced quotes from researchers warning against misinterpretation. There is no evident political agenda or biased emphasis on a
